Summit Partners’s Teladoc Health TDOC Stock Holding History

Summit Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-650,681	Closed	-$37.8M	–	10
2018 Q2	$37.8M	Buy	+650,681	New	+$31.8M	4.7%	5

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Summit Partners's TDOC Position: Q3 2018 in Review

Summit Partners sold out of Teladoc Health (TDOC) in Q3 2018, closing a stake of 650,681 shares — an estimated $37.8M sold.

Summit Partners first reported a position in TDOC in Q2 2018 and held it in 1 quarter. The position peaked at $37.8M in Q2 2018. 334 funds tracked by Wall St. Rank hold TDOC as of Q3 2018.

Summit Partners reported no remaining Teladoc Health position as of Q3 2018 after selling out during the quarter.
Summit Partners sold 650,681 Teladoc Health shares in Q3 2018, an estimated $37.8M.
Summit Partners first reported a position in Teladoc Health in Q2 2018 and held it in 1 quarter.
Summit Partners's Teladoc Health position peaked at $37.8M in Q2 2018.
334 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2018.

Based on Summit Partners's 13F filing for Q3 2018, filed 25 Oct 2018.